Acasti Pharma reported $-4760000 in Sales Revenues for its fiscal quarter ending in December of 2024.


Sales Change Date
Acasti Pharma USD -4760000 4.76M Dec/2024
Addus HomeCare USD 349.4M 11.7M Jun/2025
Amarin USD 72.74M 30.72M Jun/2025
Cassava Sciences 0 0 Dec/2024
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Option Care Health USD 1.42B 90M Jun/2025
Organigram Holdings CAD 70.79M 28.06M Jun/2025
Tilray USD 308.01M 43.78M Jun/2025